Stopping azithromycin mass drug administration for trachoma: A systematic review
Stopping azithromycin mass drug administration for trachoma: A systematic review
About this item
Full title
Author / Creator
Publisher
San Francisco: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
San Francisco: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1–9 years. Azithromycin targets the ocular strains of
Chlamydia trachomatis
that cause trachoma. Regions with low prevalence of active trachoma ma...
Alternative Titles
Full title
Stopping azithromycin mass drug administration for trachoma: A systematic review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2561939571
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2561939571
Other Identifiers
ISSN
1935-2735,1935-2727
E-ISSN
1935-2735
DOI
10.1371/journal.pntd.0009491
